Clinical Trial Update: Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing chemoradiotherapy with Gemcitabine/S-1 to Gemcitabine/S-1 for locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemcitabine (Gemcitabine)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Osaka Medical Center for Cancer and Cardiovascular Diseases | Conditions: Pancreatic Cancer | Phase 2 | Status: COMPLETED